Flu News and Research

RSS

Domestic ducks could pose new avian Influenza threat

Domestic ducks may be acting as a silent reservoir for the H5N1 Avian Influenza virus, which is highly pathogenic for chickens, and may thus have acquired an important new role in the transmission of the virus to other poultry and, possibly, to humans as well, three international agencies warned today.

10 Nov 2004

Morton Grove Pharmaceuticals increases production of antiviral flu drug, Amantadine

During the current flu vaccine shortage, the Centers for Disease Control and Prevention, Department of Health and Human Services, has issued guidance recommending the use of certain alternative antiviral medications.

8 Nov 2004

Hong Kong launches flu vaccination programme

To prevent the spread of flu in the coming peak season, it is important that the public and private sectors work together to provide influenza vaccinations to members of the public.

8 Nov 2004

New York redistributes existing flu vaccine supplies

New York State Health Commissioner Antonia C. Novello, M.D., M.P.H., Dr.P.H., has announced the New York State Department of Health has begun distribution of its current supply of flu vaccine to help address the needs of local health departments and children served by a federal vaccination program.

4 Nov 2004

Study shows possible solution to the current flu vaccine shortage

A new study led by the Saint Louis University’s Center for Vaccine Development may provide a solution to the current flu vaccine shortage in the U.S. The team found a possible way to double the available supply of influenza vaccine for adults between the ages of 18 and 60.

4 Nov 2004

New treatment option for patients who have moderately active ulcerative colitis

Results of a study presented today by a Mayo Clinic physician at the 69th Annual Scientific Meeting of the American College of Gastroenterology (ACG) in Orlando, Fla., offer a new treatment option for patients who have moderately active ulcerative colitis.

1 Nov 2004

Tamiflu significantly reduced the risk of pneumonia in patients diagnosed with flu

Treatment with the antiviral medication Tamiflu (oseltamivir phosphate) significantly reduced the risk of pneumonia in patients diagnosed with flu, according to a new retrospective cohort study of over 70,000 Americans.

1 Nov 2004

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

29 Oct 2004

An immune system in a bottle would allow faster and easier production of a flu vaccine

University of Michigan associate professor Nicholas Kotov believes that one day, the cells in those honeycombs can be used to grow spare parts for our bodies, or even an entire artificial immune system in a bottle.

26 Oct 2004

British Government report declares NHS accident and emergency, the envy of the world

With 96 per cent of patients being seen and treated quickly in NHS A&E departments, this country's emergency departments are becoming the envy of the world, according to a British Government Report.

26 Oct 2004

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

Using nonprescription, or over-the-counter (OTC), medications to treat common upper respiratory infections could save $4.75 billion a year, according to a new study conducted by researchers from Northwestern University.

26 Oct 2004

Arizona will receive 22,500 additional doses of flu vaccine

Arizona Governor Janet Napolitano announced today that Arizona will receive 22,500 additional doses of flu vaccine as early as Wednesday, and will distribute the vaccine to local health departments in the next week.

25 Oct 2004

Scientists are testing the effectiveness of a new type of flu vaccine

The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

25 Oct 2004

Three additional human cases of West Nile virus in Mississippi

Today the Mississippi Department of Health confirmed three additional human cases of West Nile virus - one in Clay County, one in DeSoto County, and one in Grenada County residents. Health officials also report one additional death that occurred in a previously reported human case from Hinds County.

25 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

BMA report hopes to raise awareness about the threat of biological weapons

A new report released today (25 October 2004) by the BMA paints a bleak picture of the global community's ability to cope with advances in biological and genetic weapons technology.

25 Oct 2004

MedImmune bumps up production of FluMist vaccine

MedImmune has announced that it is increasing its planned delivery of FluMist (Influenza Virus Vaccine Live, Intranasal) up to a total of three million doses. Originally the company had completed production of 1.1 million doses.

22 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Sinusitis and bronchitis take a significant toll on a person's ability to participate in everyday life and have a sizable economic impact, accounting for more than 30 million missed workdays each year

21 Oct 2004

Flu News and Research

Domestic ducks could pose new avian Influenza threat

Morton Grove Pharmaceuticals increases production of antiviral flu drug, Amantadine

Hong Kong launches flu vaccination programme

New York redistributes existing flu vaccine supplies

Study shows possible solution to the current flu vaccine shortage

New treatment option for patients who have moderately active ulcerative colitis

Tamiflu significantly reduced the risk of pneumonia in patients diagnosed with flu

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

An immune system in a bottle would allow faster and easier production of a flu vaccine

British Government report declares NHS accident and emergency, the envy of the world

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

Arizona will receive 22,500 additional doses of flu vaccine

Scientists are testing the effectiveness of a new type of flu vaccine

Three additional human cases of West Nile virus in Mississippi

Infectious diseases physicians call for financial incentives for industry

Who should and who should not get a flu shot?

BMA report hopes to raise awareness about the threat of biological weapons

MedImmune bumps up production of FluMist vaccine

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

Sinusitis and bronchitis account for more than 30 million missed workdays each year

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News